SBI's newest COVID-19 research tools give you the ability to express the SARS-CoV-2 spike glycoprotein or nucleocapsid with the ready-to-use convenience of mRNA. Go straight to transfection and transient expression of these critical SARS-CoV-2 proteins.
Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Credit: NIAID
“N” SARS-CoV-2 Nucleocapsid mRNA
Transiently express the SARS-CoV-2 nucleocapsid protein (N protein) in the cells of your choice with this ready-to-transfect mRNA.
- Speed your studies with ready-to-transfect mRNA
- Transiently express the native (not codon optimized) SARS-CoV-2 nucleocapsid protein
- Stable SARS-CoV-2 nucleocapsid protein expression is also available as a stable cell line, pre-packaged transduction-ready lentivirus, and ready-to-package lentivector
| CATALOG NUMBER | DESCRIPTION | SIZE |
| CVD19-420A-1 | “N” SARS-CoV-2 Nucleocapsid mRNA (10 µg, Transfection-ready) | 10 µg |
| CVD19-425A-1 | “N” SARS-CoV-2 Nucleocapsid mRNA (20 µg, Transfection-ready) | 20 µg |
“S” SARS-CoV-2 Spike Glycoprotein mRNA
Transiently express the SARS-CoV-2 spike glycoprotein (S protein) in the cells of your choice with this ready-to-transfect mRNA.
- Speed your studies with ready-to-transfect mRNA
- Transiently express the native (not codon optimized) SARS-CoV-2 spike glycoprotein
- Stable SARS-CoV-2 spike glycoprotein expression is also available as pre-packaged transduction-ready lentivirus, ready-to-package lentivector, and as a human codon-optimized construct
| CATALOG NUMBER | DESCRIPTION | SIZE |
| CVD19-430A-1 | “S” SARS-CoV-2 Spike Glycoprotein mRNA (10 µg, Transfection-ready) | 10 µg |
| CVD19-435A-1 | “S” SARS-CoV-2 Spike Glycoprotein mRNA (20 µg, Transfection-ready) | 20 µg |
